Global Markets for Treatment and Diagnosis of Sexually Transmitted Diseases

December 27, 2012

Wellesley, Mass. – According to a new technical market research report, GLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES (PHM005C), from BCC Research (www.bccresearch.com), the global market for treatment and diagnosis of sexually transmitted diseases was valued at $28.2 billion in 2011 and should reach nearly $33.3 billion in 2012.  Total market value is expected to reach nearly $52 billion in 2017 after increasing at a five-year compound annual growth rate of 9.3%.

The market for treatment and diagnosis of sexually transmitted diseases (STDs) can be broken down into two segments: diagnostic products and pharmaceutical treatments.

The segment made up of diagnostic products should total nearly $3.2 billion in 2012 and nearly $4.5 billion in 2017, a CAGR of 6.9%.

The segment made up of pharmaceutical treatments is expected to total nearly $30.1 billion in 2012 and $47.5 billion in 2017, a CAGR of 9.6%.

Improved laboratory and epidemiologic methods have enabled researchers to define more clearly the prevalence, modes of transmission, and clinical consequences of STDs. In addition, some STDs that have come to the forefront in recent years (e.g., human immunodeficiency virus/acquired immunodeficiency syndrome [HIV/AIDS], hepatitis B and C) have become epidemic or hyperepidemic as a consequence of changing sexual behavior patterns.

In many countries, including the United States, each case of syphilis and gonorrhea is required to be reported to state or local agencies. The true incidence of STDs is hard to determine, however, because variable global reporting requirements and cultural stigmas toward some STDs often mitigate accurate reporting.  

The major objectives of this study are:

• To assess the technological developments
• To identify the driving factors for demand
•  To make available the most current and reliable information on market size
• To estimate the global supply-and-demand scenario broken down by disease and geographical regions
•  To estimate the growth rate in demand
• To estimate the projected global supply-and demand-scenario over thenext five years and to analyze it via application sectors as well as product types
•  To identify the factors influencing this industry and make appropriate recommendations.  

This report will be valuable to many industry participants, including the following:

• Pharmaceutical treatment manufacturers
• Diagnostic product makers
• Academic and research institutions
• End users and distributors
• Financial institutions.

To Contact us, click here  

Global Markets for Treatment and Diagnosis of Sexually Transmitted Diseases( PHM005C )
Publish Date: Jan 2013    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.